CUE stock forecast
Our latest prediction for Cue Biopharma, Inc.'s stock price was made on the June 21, 2019 when the stock price was at 7.50$.
In the short term (2weeks), CUE's stock price should outperform the market by 3.10%. During that period the price should oscillate between -8.23% and +12.86%.
In the medium term (3months), CUE's stock price should outperform the market by 3.05%. During that period the price should oscillate between -21.19% and +33.84%.Get email alerts
About Cue Biopharma, Inc.
Cue Biopharma, Inc. is a biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded on December 31, 2014 and is headquartered in Cambridge, MA.
At the moment the company generates 2M USD in revenues.
On its last earning announcement, the company reported a loss of -2.11$ per share.
The book value per share is 2.45$
Three months stock forecastJune 21, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|